After interaction with the primary binding receptor [8], [9], however, FIV (primary and laboratory-adapted FIV strains [10]) and T-cell tropic HIV-1 strains both utilize the chemokine receptor CXCR4 as the entry receptor.
Table 2 Hydrolytic activity of P. excavatus proteases on different substrates Specific activity (U.mg-1) Fractions Fibrin Casein BA p NA BT p NA FI 602 1.8 0 0 FII 44 1 0 0 FIII-1 393 1 0.1 0 FIII-2 783 1 0.4 0 FIII-3 831 1.2 0 0 FIV 296 0.9 2.2 0. The caseinolytic activity was more or less the same for all fractions.
Similarly, the N44 region in the FIV V3 loop includes three basic residues and two aromatic tryptophan residues among over 200 FIV envelope sequences published in Genbank.
In contrast, all 3 FIV chronically infected animals exhibited robust CTL activity, ranging between 16% and 35% at E T ratio 10 1.
Furthermore, a contiguous nine-amino-acid region (SSWRQKNRW, designated N44) of FIV V3 is a neutralization target for CD134-dependent virus neutralization via blocking CXCR4 binding and virus entry [36].
Six protease fractions, namely FI, FII, FIII-1, FIII-2, FIII-3 and FIV, were isolated from Perionyx excavatus earthworm biomass by acetone precipitation, followed by serial chromatography using anion exchange, hydrophobic interaction and size exclusion chromatography.
FCV was detected in the swab from cat 2, and a double infection with FCV and FHV-1 was detected in cat 4. Clinical, bacteriologic, and virologic tests identified infection with FeLV in 15 cats, FIV in 12 cats, and antibodies against FCoV in all but 1 cat.
Fresh medium containing ethanol at 101.4 μL of 100% ethanol/100 mL of medium (80 mg/100 dL), FIV at MOI of 0.5, or ethanol (same dose) plus FIV (same dose) were added to these cultures for 24 hours.
The purpose of the present study was to further elucidate the antiviral activity spectrum of stampidine, a novel nucleoside analog with potent anti-viral activity against the immunodeficiency viruses HIV-1, HIV-2, and FIV, by examining its effects on survival of mice challenged with Lassa virus.
Stampidine (STAMP), stavudine-5'-[p-bromophenyl methoxyalaninyl phosphate], is a novel nucleoside analog with potent anti-viral activity against the immunodeficiency viruses HIV-1, HIV-2, and FIV, which may provide the basis for effective salvage therapies for patients harboring highly drug resistant strains of HIV-1 [ 27].
Given the need for an anti-viral agent to treat patients with Lassa fever, we examined the therapeutic potential of Stampidine, a novel nucleoside analog with potent anti-viral activity against the immunodeficiency viruses HIV-1, HIV-2, and FIV, in Lassa-infected mice.
